Location: Home > Pharma China Web Edition
  • search
  • go
  • Product/R&D News
  • 1/6/2025Chinese Researchers Use AI to Accelerates Discovery of Potential Glauc...
  • 1/3/2025Platinum Life Receives Conditional Approval for China's First Stem Cel...
  • 1/3/2025Gilead's Sunlenca (lenacapavir) Receives Marketing Approval in China
  • 1/3/2025Astellas' Vyloy (zolbetuximab) Receives Marketing Approval in China fo...
  • 1/3/2025Biocon Wins NMPA Approval for Tacrolimus Capsules in China
  • 12/30/2024TJ Bio Submits BLA for Genexine's Long-Acting Pediatric Growth Hormone...
  • 12/30/2024NMPA Approves Alpha/AZ's Zorifer for NSCLC
  • 12/30/20242025 New Drug Outlook: Increasing Global Launch Share of Chinese Innov...
  • 12/30/2024TEVIMBRA Approved in the U.S. as First-line Treatment of G/GEJ in Com...
  • 12/27/2024China's Innovative Drug Approvals in 2024 and Blockbusters Anticipated...
  • 12/26/2024Alphamab Initiates Phase I/II Trial for HER2 ADC Bispecific and PD-L1 ...
  • 12/25/2024Auzone Submits NDA for TTYP01 to FDA, Anticipates 2025 Approval
  • 12/24/2024Roche's Lunsumio (Mosunetuzumab) Gains NMPA Approval for r/r Follicula...
  • 12/23/2024Ascelia Pharma Secures Chinese Patent for 2nd-Generation Orviglance
  • 12/19/2024FDA Approves Betta/Xcovery's Ensartinib for NSCLC
  • 12/16/2024Sinopharm's Mpox Vaccine Gains Clinical Trial Approval in China
  • 12/16/2024Everest Medicines Announces Acceptance of the NDA for VELSIPITY
  • 12/15/2024HUTCHMED Announces Breakthru Designation in China for ORPATHYS and TA...
  • 12/15/2024US-China Renew Science and Technology Pact Amid Rising Tensions
  • 12/12/2024ARS Pharma Files for Approval of Neffy in China, Japan and Australia
  • 12/11/2024Generative AI Powers Insilico Medicine's Rapid Development of New IBD ...
  • 12/10/2024Eisai's Dotinurad Approved in China for Gout
  • 12/10/2024Huadong and Kiniksa's Rilonacept Gains Approval in China for Recurrent...
  • 12/10/2024Sperogenix's Vamorolone Approved in China for DMD
  • 12/10/2024Merck's Keytruda Gains First Approval in China for Cervical Cancer Tre...
  • 12/10/2024Dizal Presents Latest Data of DZD8586, a LYN/BTK Dual Inhibitor, in B-...
  • 12/10/2024Loncastuximab Tesirine Gains Approval in China for 3L r/r DLBCL Treatm...
  • 12/10/2024Abbisko Reports Promising Preliminary Phase 2 Data for Pimicotinib in ...
  • 12/10/2024Hong Kong Takes Key Step Towards Becoming a Medical Hub with New Clini...
  • 12/9/2024Belief Biomed Unveils Promising Gene Therapy Data at ASH 2024
  • Page:6/11 Total number of articles:323: [First][<<] [4] [5] [6] [7] [8] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group